OTC Markets OTCPK - Delayed Quote USD

NanoSphere Health Sciences Inc. (NSHSF)

0.0038
0.0000
(0.00%)
At close: May 16 at 4:00:00 PM EDT
Loading Chart for NSHSF
  • Previous Close 0.0000
  • Open 0.1000
  • Bid 0.0041 x --
  • Ask 1.0000 x --
  • Day's Range 0.1000 - 0.1000
  • 52 Week Range 0.0038 - 0.1000
  • Volume 16,000
  • Avg. Volume 4
  • Market Cap (intraday) 294,501
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 0.13
  • EPS (TTM) 0.0300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. NanoSphere Health Sciences Inc. is headquartered in Vancouver, Canada.

www.nanospherehealth.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NSHSF

View More

Performance Overview: NSHSF

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

NSHSF
86.43%
S&P/TSX Composite index (^GSPTSE)
5.49%

1-Year Return

NSHSF
81.00%
S&P/TSX Composite index (^GSPTSE)
16.47%

3-Year Return

NSHSF
95.35%
S&P/TSX Composite index (^GSPTSE)
28.53%

5-Year Return

NSHSF
99.24%
S&P/TSX Composite index (^GSPTSE)
77.42%

Compare To: NSHSF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NSHSF

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    294.50k

  • Enterprise Value

    323.19k

  • Trailing P/E

    0.13

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    1.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: NSHSF

View More

Company Insights: NSHSF

Research Reports: NSHSF

View More

People Also Watch